Leaflet CIFOBAN 136mmol / l solution for infusion


Indicated for: urinary alkalinization; metabolic acidosis

Route of administration: infusion

Substance: sodium citrate (electrolyte)

ATC: B05CB02 (Blood and blood forming organs | Irrigating solutions | Salt solutions)

Sodium citrate is a compound used in medicine as a urinary alkalinizer, anticoagulant, and corrector of electrolyte imbalances. It works by increasing urine pH, preventing kidney stone formation, and reducing urinary tract irritation.

The medication is administered orally or intravenously, as directed by a doctor, depending on the condition being treated. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor electrolyte balance.

Patients should be aware of potential side effects, such as nausea, diarrhea, or abdominal discomfort. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, and abdominal discomfort. In rare cases, severe reactions such as hypernatremia or metabolic alkalosis may occur. Patients should be informed of these risks before starting treatment.

General data about CIFOBAN 136mmol / l

  • Substance: sodium citrate
  • Commercial code: W68772001
  • Concentration: 136mmol / l
  • Pharmaceutical form: solution for infusion
  • Quantity: 8
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA
  • Holder: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA
  • Number: 14396/2022/01
  • Shelf life: 2 years-after packaging for sale; after the first opening a pungii-it is used immediately